PERK inhibition blocks metastasis initiation by limiting UPR-dependent survival of dormant disseminated cancer cells

Veronica Calvo; Wei Zheng; Kirk A. Staschke; Julie Cheung; Ana Rita Nobre; Eduardo F. Farias; Ari Nowacek; Mark Mulvihill; Alan C. Rigby; Julio A. Aguirre-Ghiso

doi:10.1101/2021.07.30.454473

New Results

PERK inhibition blocks metastasis initiation by limiting UPR-dependent survival of dormant disseminated cancer cells

Veronica Calvo, View ORCID ProfileWei Zheng, Kirk A. Staschke, Julie Cheung, Ana Rita Nobre, Eduardo F. Farias, Ari Nowacek, Mark Mulvihill, Alan C. Rigby, Julio A. Aguirre-Ghiso

doi: https://doi.org/10.1101/2021.07.30.454473

Veronica Calvo

1Division of Hematology and Oncology, Department of Medicine and Department of Otolaryngology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA

3HiberCell, Inc, 619 West 54th Street, 8th Floor, New York, NY USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Wei Zheng

1Division of Hematology and Oncology, Department of Medicine and Department of Otolaryngology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Wei Zheng

Kirk A. Staschke

2Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, IN, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Julie Cheung

1Division of Hematology and Oncology, Department of Medicine and Department of Otolaryngology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ana Rita Nobre

1Division of Hematology and Oncology, Department of Medicine and Department of Otolaryngology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Eduardo F. Farias

1Division of Hematology and Oncology, Department of Medicine and Department of Otolaryngology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA

3HiberCell, Inc, 619 West 54th Street, 8th Floor, New York, NY USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ari Nowacek

3HiberCell, Inc, 619 West 54th Street, 8th Floor, New York, NY USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Mark Mulvihill

3HiberCell, Inc, 619 West 54th Street, 8th Floor, New York, NY USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Alan C. Rigby

3HiberCell, Inc, 619 West 54th Street, 8th Floor, New York, NY USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Julio A. Aguirre-Ghiso

1Division of Hematology and Oncology, Department of Medicine and Department of Otolaryngology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: julio.aguirre-ghiso@mssm.edu

Abstract
Full Text
Info/History
Metrics
Supplementary material
Preview PDF

Supplemental figures and legends[supplements/454473_file02.pdf]

View the discussion thread.

PreviousNext

Posted July 30, 2021.

Download PDF

Supplementary Material

Thank you for your interest in spreading the word about bioRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following PERK inhibition blocks metastasis initiation by limiting UPR-dependent survival of dormant disseminated cancer cells

Message Subject (Your Name) has forwarded a page to you from bioRxiv

Message Body (Your Name) thought you would like to see this page from the bioRxiv website.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

PERK inhibition blocks metastasis initiation by limiting UPR-dependent survival of dormant disseminated cancer cells

Veronica Calvo, Wei Zheng, Kirk A. Staschke, Julie Cheung, Ana Rita Nobre, Eduardo F. Farias, Ari Nowacek, Mark Mulvihill, Alan C. Rigby, Julio A. Aguirre-Ghiso

bioRxiv 2021.07.30.454473; doi: https://doi.org/10.1101/2021.07.30.454473

Share This Article:

Citation Tools

PERK inhibition blocks metastasis initiation by limiting UPR-dependent survival of dormant disseminated cancer cells

Veronica Calvo, Wei Zheng, Kirk A. Staschke, Julie Cheung, Ana Rita Nobre, Eduardo F. Farias, Ari Nowacek, Mark Mulvihill, Alan C. Rigby, Julio A. Aguirre-Ghiso

bioRxiv 2021.07.30.454473; doi: https://doi.org/10.1101/2021.07.30.454473

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Tweet Widget
Facebook Like
Google Plus One

Subject Area

Cancer Biology

Subject Areas

All Articles

Animal Behavior and Cognition (5636)
Biochemistry (12773)
Bioengineering (9658)
Bioinformatics (31212)
Biophysics (16080)
Cancer Biology (13154)
Cell Biology (18809)
Clinical Trials (138)
Developmental Biology (10185)
Ecology (15162)
Epidemiology (2067)
Evolutionary Biology (19376)
Genetics (12867)
Genomics (17756)
Immunology (12886)
Microbiology (30158)
Molecular Biology (12586)
Neuroscience (65780)
Paleontology (485)
Pathology (2035)
Pharmacology and Toxicology (3512)
Physiology (5437)
Plant Biology (11270)
Scientific Communication and Education (1738)
Synthetic Biology (3113)
Systems Biology (7758)
Zoology (1755)